[HTML][HTML] Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy

D Chrysostomou, LA Roberts, JR Marchesi, JM Kinross - Gastroenterology, 2023 - Elsevier
Accumulating evidence supports not only the functional role of the gut microbiome in cancer
development and progression but also its role in defining the efficacy and toxicity of …

Dietary interventions in cancer treatment and response: a comprehensive review

BD Mercier, E Tizpa, EJ Philip, Q Feng, Z Huang… - Cancers, 2022 - mdpi.com
Simple Summary Chemotherapy and radiotherapy are essential components to the
management of most solid malignancies. These modalities exert their effects primarily by …

Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes

F Kalam, DL James, YR Li, MF Coleman… - JNCI …, 2023 - academic.oup.com
Intermittent fasting entails restricting food intake during specific times of day, days of the
week, religious practice, or surrounding clinically important events. Herein, the metabolic …

[HTML][HTML] Intermittent fasting and immunomodulatory effects: A systematic review

Z He, H Xu, C Li, H Yang, Y Mao - Frontiers in Nutrition, 2023 - frontiersin.org
Intermittent fasting (IF), a dietary strategy of periodic food restriction and fixed eating
windows, could beneficially modify individuals by losing body weight, regulating glucose or …

The Clinical Impact of Time-restricted Eating on Cancer: A Systematic Review

EJ Stringer, RWG Cloke, L Van der Meer… - Nutrition …, 2024 - academic.oup.com
Context In the face of the growing global burden of cancer, there is increasing interest in
dietary interventions to mitigate its impacts. Pre-clinical evidence suggests that time …

Multifaceted effects of intermittent fasting on the treatment and prevention of diabetes, cancer, obesity or other chronic diseases

P Tagde, S Tagde, T Bhattacharya… - Current Diabetes …, 2022 - ingentaconnect.com
Background: Obesity and diabetes are global epidemics resulting in a range of
comorbidities. Both have been linked to an increased risk of hormonal imbalance, cancer …

Clinicopathological variables and outcome in chronic myeloid leukemia associated with BCR-ABL1 transcript type and body weight: an outcome of European …

MAJ Abdulla, P Chandra, SE Akiki, MB Aldapt… - Cancer …, 2021 - journals.sagepub.com
Objective It is debatable whether BCR-ABL1 transcript type has an impact on outcome of
treatment of patients with CML, and it is not widely studied whether body weight influences …

Applications of machine learning in chronic myeloid leukemia

M Elhadary, AA Elsabagh, K Ferih, B Elsayed… - Diagnostics, 2023 - mdpi.com
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by
dysregulated growth and the proliferation of myeloid cells in the bone marrow caused by the …

Intermittent fasting and its impact on toxicities, symptoms and quality of life in patients on active cancer treatment

RL Sucholeiki, CL Propst, DS Hong… - Cancer Treatment …, 2024 - Elsevier
Intermittent fasting is a dietary intervention that is increasingly being tested for positive
outcomes in patients receiving cancer treatment. In this review, we examine the impact of …

The role of intermittent fasting and the ketogenic diet in cancer disease: can they replace the Mediterranean diet?

AN Küçük, S Çiftçi - European Journal of Cancer Prevention, 2023 - journals.lww.com
The prevalence of cancer is rising globally, and it is the second leading cause of death.
Nutrition has an important influence on the risk of develo** cancer. Moreover, changes in …